In addition, genetic variants of ACE2 have been linked to left ventricular hypertrophy [73,203], raising the possibility that ACE2 may contribute to cardiovascular disease in COVID-19 beyond its role as a receptor for SARS-CoV-2. The gene discussed is ACE2; the disease is COVID-19.